Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Yatharth Hospital & Trauma Care Services Ltd on NSE and BSE, with an AI summary of each filing.
We hereby submit Earnings Call Recording for Q2FY27.
Audio / Video · 04 Nov 2026, 10:03 pm
Yatharth Hospital Releases Audio Recording of Q2FY27 Earnings Call Yatharth Hospital & Trauma Care Services Limited conducted its earnings call for the quarter and half-year ended 30th Sep'26 on 4th Nov'26 at 11:00 AM IST. Pursuant to SEBI LODR Regulation 30, the company has released the official audio recording of the investor call, which is accessible via the company's designated portal link and corporate website.
We hereby submit Investor''s Presentation for Q2FY27.
Investor Presentation · 03 Nov 2026, 7:52 pm
Yatharth Hospital Reports Strong Q2FY27 Results and Strategic Advent Partnership Yatharth Hospital reported robust Q2FY27 financial performance, with revenue rising 52% YoY to Rs 4,314 mn (+10% QoQ) and EBITDA increasing 50% YoY to Rs 1,020 mn (+11% QoQ) at a 23.6% margin. PAT grew 17% YoY to Rs 485 mn. ARPOB expanded 11% YoY to Rs 35,948 with 72% occupancy across 1,820 operational beds. Advent will infuse Rs 3,150 crore primary capital for a 24.9% stake, accelerating bed capacity targets to 7,000–8,000 beds over the next 3–5 years.
We hereby submit Press Release for Financial Results for Q2FY27.
Press Release · 03 Nov 2026, 7:39 pm
Yatharth Hospitals Q2 FY27 Results and Advent Capital Infusion Yatharth Hospital reported robust Q2 FY27 results, with revenue rising 52% YoY to Rs 4,314 mn and EBITDA increasing 50% YoY to Rs 1,020 mn (margin at 23.6%; adjusted EBITDA margin at 28%). PAT grew 17% YoY to Rs 485 mn, while ARPOB reached Rs 35,948 (+11% YoY). New hospitals contributed 28% of quarterly revenue. Additionally, the company entered a definitive agreement with Advent International for a primary investment of Rs 3,150 crore (~24.9% stake upon full conversion) to fund network expansion towards 7,000–8,000 beds.
We hereby submit Unaudited Financial Results for the second quarter and half year ended September 30, 2026.
Financial Result · 03 Nov 2026, 7:36 pm
We hereby submit Outcome of the Board Meeting of the Company held on today. i.e. November 03, 2026.
Outcome · 03 Nov 2026, 7:32 pm
Yatharth Hospital Reports Strong Q2 Results with Advent International Stake Deal Yatharth Hospital & Trauma Care Services reported consolidated revenue from operations of INR 4,314.20 million for the quarter ended 30th Sep'26, up 52.4% YoY from INR 2,830.14 million. Net profit increased 17.5% YoY to INR 484.59 million, with basic EPS rising to INR 5.25. For H1 ended 30th Sep'26, consolidated revenue stood at INR 8,240.74 million and net profit reached INR 938.82 million. Shareholders approved Advent International acquiring a 24.9% equity stake via Rasmalai Limited, subject to pending regulatory clearances.
We hereby submit Outcome of the Board Meeting of the Company held on today. i.e. November 03, 2026.
Outcome · 03 Nov 2026, 7:30 pm
Yatharth Hospital Reports Strong Q2 FY27 Consolidated Results; Advent Stake Sale Approved Yatharth Hospital & Trauma Care Services posted a 52.4% YoY surge in consolidated revenue from operations to INR 4,314.20 mn for the quarter ended 30th Sep'26, while net profit grew 17.5% YoY to INR 484.59 mn (INR 505.87 mn attributable to owners). Standalone revenue rose 40.9% YoY to INR 1,949.06 mn with net profit at INR 370.61 mn. Shareholders approved Advent International affiliate Rasmalai Limited acquiring a 24.9% equity stake on a fully diluted basis on 15th Oct'26, pending regulatory clearances.
We hereby submit Schedule of Earnings Conference Call Q2FY27.
Intimation · 04 Nov 2026, 11:00 am
Yatharth Hospital Schedules Q2FY27 Earnings Conference Call for 4th Nov'26 Yatharth Hospital & Trauma Care Services Limited will host its Q2FY27 earnings conference call on 4th Nov'26 at 11:00 AM IST, organized by Elara Securities. The call follows the declaration of standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Senior leadership, including Whole-Time Director Yatharth Tyagi, Group CEO Amit Kumar Singh, Group COO Nitin Gupta, and Group CFO Pankaj Prabhakar, will represent the company to discuss operational performance and financial results. Universal dial-in numbers include +91 22 6280 1146.
Yatharth Hospital & Trauma Care Services Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
To consider and approve the Unaudited Financial Results for Q2FY27.
Intimation · 03 Nov 2026, 5:30 am
Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited ....
Intimation · 03 Nov 2026, 5:30 am
Yatharth Hospital Board Meeting Scheduled for 3rd Nov'26 to Approve Q2 Results Yatharth Hospital & Trauma Care Services Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26, along with the Limited Review Report. Additionally, the trading window for dealing in company securities by designated persons and their immediate relatives has been closed since 1st Oct'26 and will remain shut until 48 hours post the public declaration of the financial results.
We hereby submit the Scrutinizer''s Report of the 1st/2026-27 Extra-Ordinary General Meeting of the Company held on October 15, 2026.
Extra Ordinary General Meeting · 16 Oct 2026, 11:19 pm
Yatharth Hospital Shareholders Approve Preferential Issue and Capital Hike at EGM Yatharth Hospital & Trauma Care Services secured requisite shareholder approval for all five resolutions at its EGM on 15th Oct'26. Passed proposals include increasing authorized share capital (99.99% votes in favor), issuing equity shares and warrants via preferential placement (99.26%), adopting amended Articles of Association granting special investor rights (91.71%) and promoter rights (89.54%), and approving an upside share arrangement under the Investment Agreement (61.55%). Total voting turnout represented 70.44m shares out of 96.35m eligible equity shares across the key capital-raising resolutions.
We hereby submit the Voting Results of the 1st/2026-27 Extra-Ordinary General Meeting of the Company held on October 15, 2026.
Extra Ordinary General Meeting · 16 Oct 2026, 11:15 pm
Yatharth Hospital Shareholders Approve Capital Hike, Preferential Issue, and Key Agreements Shareholders of Yatharth Hospital & Trauma Care Services approved all resolutions at the EGM held on 15th Oct'26. Key approvals include increasing authorized share capital (99.99% favor), issuing equity shares and warrants via preferential issue (99.26% favor), and adopting amended Articles of Association granting special rights to investors (91.71% favor) and promoters (89.54% favor). Additionally, the Upside Share Arrangement under the Investment Agreement passed with 61.55% majority, enabling execution of strategic equity expansion plans.
We hereby submit the summary of Proceedings of the 1st/2026-27 Extra-Ordinary General Meeting of the Company held today i.e. October 15, 2026.
Extra Ordinary General Meeting · 15 Oct 2026, 9:56 pm
Yatharth Hospital EGM Approves Preferential Issue to Advent International Affiliate Yatharth Hospital & Trauma Care Services Limited conducted an EGM on 15th Oct'26 to approve key strategic resolutions. Shareholders voted on a proposed strategic investment by Rasmalai Limited, an affiliate of Advent International, via a preferential issue of equity shares and warrants. Additional transacted business included increasing authorized share capital, amending Articles of Association to grant special rights to the investor and promoters, and approving an upside share arrangement under the investment agreement to fund growth and fortify the balance sheet. Scrutinizer voting results will be submitted separately.
We hereby submit Corrigendum to the Notice of the 1st/2026-27 Extra-Ordinary General Meeting to be held on October 15, 2026.
Extra Ordinary General Meeting · 06 Oct 2026, 10:44 pm
Yatharth Hospital Issues Corrigendum for Preferential Issue of Shares and Warrants Yatharth Hospital issued an EGM corrigendum clarifying details on its proposed preferential issue of up to 1,30,26,516 equity shares (aggregating INR 1,283.33 Cr) and up to 1,89,47,664 warrants at an issue price of INR 985.17 per security. Warrants carry an 18-month maximum tenure with 25% payable upfront. Proceeds will primarily fund hospital network expansion, infrastructure development, subsidiary investments, and general corporate purposes over a three-year timeline. CRISIL Ratings has been appointed as the monitoring agency to oversee fund deployment. EGM is scheduled for 15th Oct'26.
We hereby submit the Scrutinizer''s Report of 19th Annual General Meeting of the Company held on September 25, 2026.
Annual General Meeting · 26 Sept 2026, 3:25 am
We hereby submit the Voting Results of the 19th Annual General Meeting of the Company held on September 25, 2026.
Annual General Meeting · 26 Sept 2026, 3:18 am
We hereby submit the summary of the Proceedings of 19th Annual General Meeting of the Company held today i.e. September 25, 2026.
Annual General Meeting · 25 Sept 2026, 10:12 pm
We hereby submit intimation regarding Schedule of Analyst/Investor Meet.
Intimation · 24 Sept 2026, 12:24 am
Yatharth Hospital Schedules Investor Meetings in Mumbai on Sep'26 Yatharth Hospital & Trauma Care Services management will participate in investor interactions in Mumbai. The company is scheduled to attend the Nuvama Emerging India CEO Forum on 28th Sep'26, followed by 1-on-1 and group sell-side meetings on 29th Sep'26. No unpublished price sensitive information will be shared during these interactions.
We hereby submit Notice of 1st/2026-27 Extra-Ordinary General Meeting of the Company.
Extra Ordinary General Meeting · 23 Sept 2026, 2:52 am
We hereby submit intimation regarding amendments to Memorandum and Articles of Association.
Others (Uncategorized) · 17 Sept 2026, 10:29 pm
Yatharth Hospital Approves INR 3,150 Cr Preferential Issue to Rasmalai Limited Yatharth Hospital's board approved raising up to INR 3,150.00 Cr via a preferential allotment to Cyprus-based Rasmalai Limited at INR 985.17 per security. The issuance comprises 1.30 Cr equity shares (INR 1,283.33 Cr) and 1.89 Cr warrants (INR 1,866.67 Cr; 25% upfront), representing a 24.87% fully diluted post-issue stake without change of control. Additionally, authorized share capital will increase to INR 150 Cr from INR 115 Cr. The investor secures two board seats, while promoter Ajay Tyagi gains a graded profit-sharing upside for returns exceeding 3x MoIC.
We hereby submit Issuance and allotment of equity shares and warrants of the Company by way of preferential issue on a private placement basis.
Others (Uncategorized) · 17 Sept 2026, 8:17 pm
Yatharth Hospital Approves INR 3,150 Cr Preferential Issue to Rasmalai Limited Yatharth Hospital’s board approved raising up to INR 3,150 Cr on 17th Sep'26 via a preferential issue to Cyprus-based Rasmalai Limited, representing a 24.87% fully diluted post-issue stake. The transaction includes issuing up to 1.30 Cr equity shares and 1.89 Cr warrants at INR 985.17 each (25% upfront for warrants). The board also approved increasing authorized share capital from INR 115 Cr to INR 150 Cr, granting investor board seats, and an upside-sharing agreement for promoters if investor returns exceed 3x MoIC, subject to shareholder approval on 15th Oct'26.
We hereby submit Press Release
Press Release · 17 Sept 2026, 5:40 pm
Advent International to Invest Rs 3,150 Crore in Yatharth Hospitals for 24.9% Stake Advent International entered into a definitive agreement on 17th Sep'26 to invest Rs 3,150 crore of primary capital into Yatharth Hospital and Trauma Care Services Ltd. for a 24.9% minority stake. The Tyagi Family remains the largest shareholder. The primary infusion will support Yatharth's expansion across North India, where it currently operates nine multi-speciality hospitals with ~2,800 operational beds and an announced total capacity of ~3,250 beds. The transaction remains subject to customary closing conditions.
We hereby submit Outcome of Board Meeting held on September 17, 2026.
Outcome · 17 Sept 2026, 5:32 pm
We hereby submit outcome of Board Meeting held on September 17, 2026.
Outcome · 17 Sept 2026, 5:24 pm
Yatharth Hospital Approves INR 3,150 Crore Preferential Issue to Rasmalai Limited Yatharth Hospital’s board approved raising up to INR 3,150.00 crore on 17th Sep'26 via a preferential allotment to Cyprus-based Rasmalai Limited. The issue comprises 1.30 crore equity shares and 1.89 crore warrants at INR 985.17 per security (floor price INR 984.70), representing a 24.87% post-issue fully diluted stake. The board also approved increasing authorized share capital from INR 115 crore to INR 150 crore, granting governance and board nomination rights to the investor, and convening an EGM on 15th Oct'26 for shareholder approval.
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 17-Sep-2026 to consider Fund raising.
Intimation · 15 Sept 2026, 12:19 am